The NCI has launched the Molecular Characterization Initiative, which will provide tumor sequencing to children, adolescents, and young adults receiving clinical care at a Children’s Oncology Group–affiliated hospital. By examining tumors at a molecular level, oncologists can make a more precise diagnosis, help determine what might be driving the cancer’s growth, and assess patients’ eligibility for clinical trials.

You do not currently have access to this content.